Advances in the laboratory diagnostics of acute pancreatitis

References

• Jaakkola M, Nordback I. Pancreatitis in Finland between 1970 and 1989. Gut 1993; 34: 1255–60
   PubMed Web of Science ®Google Scholar
• Marshall J B. Acute pancreatitis, a review with emphasis on new developments. Arch Intern Med 1993; 153: 1185–98
   PubMed Web of Science ®Google Scholar
• Steinberg W M, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330: 1198–210
   PubMed Web of Science ®Google Scholar
• Puolakkainen P, Valtonen V, Paananen A, Schroder T. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of severity of acute pancreatitis. Gut 1987; 28: 764–71
   PubMed Web of Science ®Google Scholar
• Clavien P A, Burgan S, Moossa A R. Serum enzymes and other laboratory tests in acute pancreatitis. Br J Surg 1989; 76: 1234–43
   PubMedGoogle Scholar
• Scholmerich J, Heinisch A, Leser H-G. Diagnostic approach to acute pancreatitis: diagnosis, assessment of etiology and prognosis. Hepatogastroenterology 1993; 40: 531–7
   PubMedGoogle Scholar
• Werner M, Steinberg W M, Pauley C. Strategic use of individual and combined enzyme indicators for acute pancreatitis analyzed by receiver operating characteristics. Clin Cbem 1989; 35: 967–71
   PubMedGoogle Scholar
• Balthazar E J, Freeny P C, van Sonnenberg E. Imaging and interventions in acute pancreatitis. Radiology 1994; 193: 297–306
   PubMed Web of Science ®Google Scholar
• Agarwal N, Pitchumoni C S, Sivaprasad A. Evaluating tests for acute pancreatitis. Am J Gastroenterol 1990; 85: 356–66
   PubMed Web of Science ®Google Scholar
• Lott J A, Patel S T, Sawhney A K, Kazmierczak S C. The importance of objective data in the diagnosis of pancreatitis. Clin Cbrni Acta 1989; 183: 33–40
   PubMedGoogle Scholar
• Wong E CC, Butch A W, Rosenblum J L, Ladensson J H, Scott M G. The clinical chemistry laboratory and acute pancreatitis. Clin Cbem 1993; 39: 234–43
   PubMedGoogle Scholar
• Wilson C, Imrie C W, Carter D C. Fatal acute pancreatitis. Gut 1988; 29: 782–8
   PubMed Web of Science ®Google Scholar
• Brooks F P. Testing pancreatic function. N Engl J Med 1972; 286: 300–3
   PubMed Web of Science ®Google Scholar
• Clavien P A, Robert J H, Meyer P, Borst F, Hauser H, Rohner A. Acute pancreatitis and normoamylasinemia: not an uncommon combination. Arch Surg 1989; 210: 614–20
   Google Scholar
• Nordback I. Value of monitoring amylase activities in patients with pancreatitis. Lancet 1985; ii: 1092
   Google Scholar
• Larvin M. Circulating mediators in acute pancreatitis as predictors of severity. Scand J Gastroenterol 1996; 31(Suppl 219)16–9
   Google Scholar
• Ranson J, Rifkind K, Roses D, Fink S, Eng K, Spencer F. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139: 69–81
   PubMedGoogle Scholar
• Kassel B, Kay J. Zymogens of proteolytic enzymes. Science 1973; 180: 1022–7
   PubMed Web of Science ®Google Scholar
• Bohe M, Borgstrom A, Lindstrom C, Ohlsson K. Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol 1986; 39: 786–93
   PubMed Web of Science ®Google Scholar
• Terada T, Kita T, Nakanuma Y. Extrahcpatic peribilary glands express amylase isoenzymes, trypsin and pancreatic lipase: an immunohistochemical analysis. Hepatology 1993; 18: 803–8
   PubMedGoogle Scholar
• Terada T, Nakanuma Y. Immunohistochemical demonstration of pancreatic alpha-amylase and trypsin in intrahepatic bile ducts and peribilary glands. Hepatology 1991; 14: 1129–35
   PubMed Web of Science ®Google Scholar
• Koivunen E, Itkonen O, Halila H, Stenman U-H. Cyst fluid of ovarian cancer contains high concentrations of trypsino-gen-2. Cancer Res 1990; 50: 2375–8
   PubMed Web of Science ®Google Scholar
• Gumaste W. Role of cathepsin B in the pathogenesis of acute pancreatitis. Gastroenterology 1994; 106: 1123–5
   PubMedGoogle Scholar
• Moller-Petersen J. Clinical evaluation of cathodic trypsin-like immunoreactivity in pancreatic diseases in adults. Scand J Clin Lab Invest 1990; 50: 463–77
   PubMedGoogle Scholar
• Whitcomb D, Gorry M, Preston R, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 4: 141–6
   Google Scholar
• Kimland M, Russick C, Marks W H, Borgstrom A. Immunoreactive anionic and cationic trypsin in human serum. Clin Cbim Acta 1989; 184: 31–46
   PubMed Web of Science ®Google Scholar
• Rinderknecht H, Geokas M C. Anionic and cationic trypsinogens (trypsins) in mammalian pancreas. Enzyme 1973; 14: 116–30
   Google Scholar
• Borgstrom A, Ohlsson K. Studies on the turnover of endogenous cathodal trypsinogen in man. Eur J Clin Invest 1978; 8: 379–82
   PubMed Web of Science ®Google Scholar
• Rinderknecht H, Renncr G I, Carmack C. Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas. Gut 1979; 20: 886–91
   PubMed Web of Science ®Google Scholar
• Itkonen O, Koivunen E, Hurme M, Alfthan H, Schroder T, Stenman U-H. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990; 115: 712–8
   PubMed Web of Science ®Google Scholar
• Navarro S, Aused R, Casals E. Value of P-amylase as an indicator of long term prognosis of acute pancreatitis. Br J Surg 1987; 74: 405–7
   PubMedGoogle Scholar
• Steinberg W, Goldstein S S, Davis N D, Shamma'a J, Anderson K. Diagnostic assays in acute pancreatitis. A study of sensitivity and specificity. Ann Intern Med 1985; 102: 576–80
   PubMed Web of Science ®Google Scholar
• Mero M, Schroder T, Tenhunen R, Lempinen M. Serum phospholipase A2, immunoreactive trypsin and trypsin inhibitor during acute pancreatitis. Scand J Gastroenterol 1982; 17: 413–7
   PubMed Web of Science ®Google Scholar
• Hedstrom J, Lcinonen J, Sainio V, Stenman U-H. Time resolved immunofluorometric assay of trypsinogen-2 complexed with alpha-1-antitrypsin in serum. Clin Cbem 1994; 40: 1761–5
   PubMed Web of Science ®Google Scholar
• Hedstrom J, Sainio V, Kcmppainen E, et al. Serum complex of trypsin-2 and alpha1-antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. BMJ 1996; 313: 333–7
   PubMed Web of Science ®Google Scholar
• Hedstrom J, Sainio V, Kemppainen E, et al. Urine trypsinogen-2 as a marker of acute pancreatitis. Clin Cbem 1996; 42: 685–90
   PubMed Web of Science ®Google Scholar
• Sainio V, Puolakkainen P, Kemppainen E, et al. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 1996; 31: 818–24
   PubMed Web of Science ®Google Scholar
• Hedström J, Korvuo A, Kenkimäki P, et al. Urinary trypsinogen test strip, a new rapid test for acute pancreatitis. Lancet 1996; 729: 729–31
   Google Scholar
• Kemppainen E, Hedstrom J, Puolakkainen P, et al. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med 1997; 336: 1788–93
   PubMed Web of Science ®Google Scholar
• Kemppainen E, Hedstrom J, Puolakkainen P, et al. Increased serum trypsinogen-2 and trypsin-2-α1-antitrypsin complex values identify ERCP-induced pancreatitis with high accuracy. Gut 1997; 41: 690–5
   PubMedGoogle Scholar
• Hedstrom J, Haglund C, Haapiainen R, Stenman U-H. Serum trypsinogen-2 and trypsin-2-1antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas. Int J Cancer 1996; 66: 326–31
   PubMed Web of Science ®Google Scholar
• Hurley P, Cook A, Jehanli A, Austen B M, Herman Taylor J. Development of radioimmunoassay for free tetraaspartyl-L-lysine trypsinogen activation peptide (TAP). J Immunol Methods 1988; 111: 29–35
   Google Scholar
• Heath D F, Wilson C, Gudgeon A M, Jehanli A, Shenkin A, Imrie C W. TAP concentrations in peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994; 35: 1311–5
   PubMedGoogle Scholar
• Banks P A, Carr-Locke D L, Slivka A, Van-Dam J, Lichtenstein D R, Hughes M. Urinary trypsinogen activation peptides (TAP) are not increased in ERCP-induced pancreatitis. Pancreas 1996; 12: 294–7
   PubMedGoogle Scholar
• Gudgeon A M, Health D I, Hurley P, et al. Trypsinogen activation peptide assay in the early prediction of severity of acute pancreatitis. Lancet 1990; i: 4–8
   Google Scholar
• Nevalainen T J. The role of phospholipase A, in acute pancreatitis. Scand J Gastroenterol 1980; 15: 641–50
   PubMed Web of Science ®Google Scholar
• Schroder T, Lempinen M, Kivilaakso E, Nikki P. Serum phospholipase A, and pulmonary changes in acute fulminant pancreatitis. Resuscitation 1982; 10: 79–82
   PubMed Web of Science ®Google Scholar
• Hietaranta A. Pancreatic Phospholipase A, in Experimental Acute Pancreatitis in the Rat. Turku University, TurkuFinland 1994, dissertation
   Google Scholar
• Nevalainen T J, Grönroos J M, Kortesuo P T. Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis. Gut 1993; 34: 1133–6
   PubMed Web of Science ®Google Scholar
• Heath D I, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie C W. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41–5
   PubMed Web of Science ®Google Scholar
• Nevalainen T J, Kallajoki M, Pesonen E, Andersson S, Kiirkkaincn P, Htickerstedt K. Origin of circulating group II phospholipase A, in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab Invest 1996; 74: 3–23
   Google Scholar
• Tocker J E, Durham S K, Welton A F, Selig W M. Phospholipase A,-induced pulmonary and hemodynamic responses in the guinea pig. Effects of enzyme inhibitor and mediator antagonists. Am Rev Respir Dis 1990; 142: 1193–9
   PubMedGoogle Scholar
• Gronroos J M, Nevalainen T J. Increased concentration of synovial-type phospholipase A2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion 1992; 52: 232–6
   PubMedGoogle Scholar
• Gronroos J M, Hietaranta A J, Nevalainen T J. Renal tubular cell injury and serum phospholipase A2 activity in acute pancreatitis. Br J Surg 1992; 79: 800–1
   PubMed Web of Science ®Google Scholar
• Gudgeon A M, Patel G, Hermon-Taylor J, et al. Detection of human pro-phospholipase A2 activation using an immunoassay for the free activation peptide DSGISPR. Ann Clin Biochem 1991; 28: 497–503
   PubMedGoogle Scholar
• Heath D I, Cruickshank A, Gudgeon A M, Jehanli A, Shenkin A, Imrie C W. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995; 10: 347–53
   PubMed Web of Science ®Google Scholar
• Keim V, Iovanna J L, Orelle B, et al. A novel exocrine protein associated with pancreatic transplantation in humans. Gastroenterology 1992; 103: 248–54
   PubMedGoogle Scholar
• Iovanna J L, Keim V, Nordback I, et al. Serum levels of pancreatis-associated protein as indicators of the course of acute pancreatitis. Gastroenterology 1994; 106: 728–34
   PubMed Web of Science ®Google Scholar
• Kemppainen E, Sand J, Puolakkainen P, et al. Pancreatitis associated protein as an early marker of acute pancreatitis. Gut 1996; 39: 675–8
   PubMed Web of Science ®Google Scholar
• Masciotra L, Lechene de la Porte P, Frigerio J-M, Dusetti N J, Dagorn J C, Iovanna J L. Immunohistochemical localization of pancreatitis-associated protein in human small intestine. Dig Dis Sci 1995; 40: 519–24
   PubMedGoogle Scholar